4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000091
Chief Commercial Officer gave up 1,485 shares (to pay taxes)
- Chief Commercial Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Poddar Richa · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-15 | Exercise or conversion : show line 1 in the form | +5,000 | 9,993 | D | ||
| 2022-10-17 | Shares withheld for taxes : show line 2 in the form | −1,485 | $27.48 | $40,808 | 8,508 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-15 | Exercise or conversion : show line 3 in the form Restricted stock units | −5,000 | 0 | D |
Loading xslF345X03/wf-form4_166612418262958.xml…